CytomX Therapeutics, Inc. (FRA:6C1)
Germany
· Delayed Price · Currency is EUR 3.374
+0.086 (2.62%)
At close: Dec 4, 2025
177.47% (1Y)
| Market Cap | 592.79M |
| Revenue (ttm) | 96.85M |
| Net Income (ttm) | 23.88M |
| Shares Out | n/a |
| EPS (ttm) | 0.20 |
| PE Ratio | 24.82 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 540 |
| Open | 3.374 |
| Previous Close | 3.288 |
| Day's Range | 3.374 - 3.374 |
| 52-Week Range | 0.384 - 3.822 |
| Beta | n/a |
| RSI | 52.95 |
| Earnings Date | Mar 6, 2026 |